Therapeutic use of at least one botulinum neurotoxin in the treatment of pain induced by at least one anti-neoplastic agent
AssigneeIpsen Pharma S.A.S.
InventorsChristine Favre, Michel Auguet, Pierre-Etienne Chabrier De Lassauniere
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method of treating or preventing pain or pains induced by an anti-neoplastic agent, comprising the step of administering an effective amount of at least one botulinum neurotoxin to a patient in need thereof.
Claims16
A method of treating post-chemotherapy pain or pains in a patient in need thereof, comprising the step of administering by an intramuscular, intradermal, or subcutaneous route at least one botulinum neurotoxin at a dose between 0.01 to 1500 U, thereby providing systemic effect against the post-chemotherapy pain or pains.
A method of treating post-chemotherapy pain or pains in a patient in need thereof comprising the step of administering by an intramuscular, intradermal, or subcutaneous route at least one botulinum neurotoxin at a dose of 20 U/kg, thereby providing systemic effect against the post-chemotherapy pain or pains within 3 days from botulinum toxin injection.
Dependencies are inferred from the claim text.